Pyrrole-based partial peptidic mimic of neurotensin (8-13): Design and synthesis

被引:2
|
作者
Zaidi, JH [1 ]
Naeem, F
Ambreen, N
Khan, KM
Pang, YP
Cusack, B
Richelson, E
Anwar, A
Voelter, W
机构
[1] Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan
[2] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem Sci, Karachi 75270, Pakistan
[3] Mayo Fdn Med Educ & Res, Neurochem & Neuropharmacol Res, Jacksonville, FL 32224 USA
[4] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany
关键词
neurotensin; partial peptidic mimic; drug design; synthesis;
D O I
10.2174/157017806774964530
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The synthesis of pyrrole-based semipeptidic mimic of neuropeptide neurotensin (8-13) [NT(8-13)] is described. The design of this NT mimic is based on substitution of indole by a pyrrole nucleus.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 50 条
  • [21] NEW NEUROTENSIN 8-13 MIMETICS WITH POTENT IN-VIVO ACTIVITY
    WUSTROW, DJ
    WISE, LD
    DAVIS, MD
    CODY, WL
    AKUNNE, HC
    CORBIN, AE
    WILEY, JN
    HEFFNER, TG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 8 - MEDI
  • [22] Tunable electrochemical synthesis of pyrrole-based adsorbents
    Pandey, Avinash Kumar
    Mishra, Abhishek Kumar
    SEPARATION SCIENCE AND TECHNOLOGY, 2020, 55 (18) : 3329 - 3342
  • [23] Biomimetic synthesis of pyrrole-based natural products
    Maki, Brooks
    Pino, Derek
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [24] Synthesis of metabolically stable 99mTc-labeled neurotensin(8-13) analogs for tumour diagnosis
    Maes, Veronique
    Tourwe, Dirk
    Blauenstein, Peter
    Garcia-Garayoa, Elisa
    Peptides 2004, Proceedings: BRIDGES BETWEEN DISCIPLINES, 2005, : 898 - 899
  • [25] SYNTHESIS OF METABOLICALLY STABLE 99MTC-LABELLED NEUROTENSIN(8-13) ANALOGS FOR TUMOR DIAGNOSIS
    Maes, V.
    Tourwe, D.
    Blaeuenstein, P.
    Garayoa, E. Garcia
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 253 - 253
  • [26] Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors
    Pfefferkorn, Jeffrey A.
    Song, Yuntao
    Sun, Kuai-Lin
    Miller, Steven R.
    Trivedi, Bharat K.
    Choi, Chulho
    Sorenson, Roderick J.
    Bratton, Larry D.
    Unangst, Paul C.
    Larsen, Scott D.
    Poel, Toni-Jo
    Cheng, Xue-Min
    Lee, Chitase
    Erasga, Noe
    Auerbach, Bruce
    Askew, Valerie
    Dillon, Lisa
    Hanselman, Jeffrey C.
    Lin, Zhiwu
    Lu, Gina
    Robertson, Andrew
    Olsen, Karl
    Mertz, Thomas
    Sekerke, Catherine
    Pavlovsky, Alexander
    Harris, Melissa S.
    Bainbridge, Graeme
    Caspers, Nicole
    Chen, Huifen
    Eberstadt, Matthias
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4538 - 4544
  • [27] In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues
    Kokko, KP
    Hadden, MK
    Orwig, KS
    Mazella, J
    Dix, TA
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) : 4141 - 4148
  • [28] Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)
    Sousbie, Marc
    Vivancos, Melanie
    Brouillette, Rebecca L.
    Besserer-Offroy, Elie
    Longpre, Jean-Michel
    Leduc, Richard
    Sarret, Philippe
    Marsault, Eric
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 7103 - 7115
  • [29] Biodistribution and catabolism of 18F-labeted neurotensin(8-13) analogs
    Bergmann, R
    Scheunemann, M
    Heichert, C
    Mäding, P
    Wittrisch, H
    Kretzschmar, M
    Rodig, H
    Tourwé, D
    Iterbeke, K
    Chavatte, K
    Zips, D
    Reubi, JC
    Johannsen, B
    NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (01) : 61 - 72
  • [30] Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators
    Teodoro, Rodrigo
    Faintuch, Bluma Linkowski
    Fernandez Nunez, Eutimio Gustavo
    Queiroz, Rodrigo Guimaraes
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (01) : 113 - 120